Načítá se...
In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
BACKGROUND: Drug repositioning refers to the identification of new indications for existing drugs. Drug-based inference methods for drug repositioning apply some unique features of drugs for new indication prediction. Complementary information is provided by these different features. It is therefore...
Uloženo v:
| Vydáno v: | BMC Bioinformatics |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868667/ https://ncbi.nlm.nih.gov/pubmed/33557749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-021-03988-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|